Pulished : October, 2018
ID: 70
Region: Global
Share on

The Global Cervical Cancer Diagnostics and Therapeutics Market is predicted to reach $4411.48 USD million with a CAGR of 4.50% according to Market Data Forecast report

Pulished: October, 2018
ID: 70
Share on

The Global Cervical Cancer Diagnostics and Therapeutics Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Global Cervical Cancer Diagnostics and Therapeutics Market is estimated to be $3540.00 USD million and predicted to rise to $ 4411.48 USD million with a CAGR of 4.50%. The market is segmented by diagnostics test (Pap smear test, HPV testing, colposcopy, cervical cancer biopsy), by methods (molecular method, cytopathological method, physical method), by therapies (surgery, radiation therapy, chemotherapy and others) and by end-users (hospitals, laboratories, independent physicians, clinics, and others). Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.

The market is mainly driven by the growth growing awareness of cervical cancer screening programs, with increasing prevalence of human papillomavirus infected patients globally. But, the growth is constrained due to high cost of screening test and uncertain reimbursement scenario.

Pap smear test segment dominated the market by Diagnostic test, holding a 45% share in the global market for cervical cancer diagnostic tests. The high growth rate of this segment can be attributed to the high efficiency of the test, low cost of the test in comparison with other tests available in the market, and rising awareness regarding cancer diagnosis. 

North America holds the largest share of the global market, followed by Europe. A number of factors such as rising prevalence of cervical cancer, growing awareness of cervical cancer screening programs, and government support are driving the growth of the HPV testing market in the North American region. Asia Pacific market is growing at very high rate, due to rising consumer market, favorable government support for enhanced healthcare infrastructure, and rising awareness for healthcare among the population in developing nations of the region.

Abbott Diagnostics, Alere, Beckman Coulter, Clinical Genomics, Companion Dx, EDP Biotech, Epigenomics AG, Exact Sciences, Fujirebio, Genomic Tree, Metabiomics, Oncocyte (Biotime), Quest Diagnostics, Randox Laboratories, Siemens Healthcare, Volition Rx, are the major players of Global Cervical Cancer Diagnostics and Therapeutics market.

Browse through the full report at “http://www.marketdataforecast.com/market-reports/global-cervical-cancer-diagnostics-and-therapeutics-market-829/” and checkout our recent reports in the Therapeutics category at “http://www.marketdataforecast.com/research-reports/healthcare/therapeutics-11/”. For more insights and up-to-date industry news don’t forget subscribing to our newsletters.